✦ LIBER ✦

Sunitinib rechallenge in metastatic renal cell carcinoma patients

✍ Scribed by Ivan N. Zama; Thomas E. Hutson; Paul Elson; James M. Cleary; Toni K. Choueiri; Daniel Y.C. Heng; Nikhil Ramaiya; M. Dror Michaelson; Jorge A. Garcia; Jennifer J. Knox; Bernard Escudier; Brian I. Rini

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 278 KB
Volume: 116
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25583

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sunitinib-induced macrocytosis in patien

Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma

✍ Brian I. Rini; Toni K. Choueiri; Paul Elson; Mohamad K. Khasawneh; Claudiu Cotta 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 1 views

Sunitinib in metastatic renal cell carci

Sunitinib in metastatic renal cell carcinoma patients with brain metastases

✍ Martin E. Gore; Subramanian Hariharan; Camillo Porta; Sergio Bracarda; Robert Ha 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB

Prognostic nomogram for sunitinib in pat

Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma

✍ Robert J. Motzer; Ronald M. Bukowski; Robert A. Figlin; Thomas E. Hutson; M. Dro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 3 views

## Abstract ## BACKGROUND. In a randomized, phase 3 trial, sunitinib demonstrated superior efficacy over interferon‐alfa as first‐line therapy in patients with metastatic clear‐cell renal cell carcinoma (RCC). On the basis of outcome data from that trial, the authors developed a nomogram for predi

Sorafenib in patients with metastatic re

Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab

✍ Jorge A. Garcia; Thomas E. Hutson; Paul Elson; C. Lance Cowey; Timothy Gilligan; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 2 views

Phase 1 dose-escalation trial of tremeli

Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma

✍ Brian I. Rini; Mark Stein; Pat Shannon; Simantini Eddy; Allison Tyler; Joe J. St 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 2 views

The impact of tumor burden characteristi

The impact of tumor burden characteristics in patients with metastatic renal cell carcinoma treated with sunitinib

✍ Naveen S. Basappa; Paul Elson; Ali-Reza Golshayan; Laura Wood; Jorge A. Garcia; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 2 views